Exploring the components and mechanism of Solanum nigrum L. for colon cancer treatment based on network pharmacology and molecular docking

被引:8
作者
Chen, Jin-Fang [1 ,2 ]
Wu, Shi-Wei [1 ,2 ]
Shi, Zi-Man [1 ,2 ]
Qu, Yan-Jie [3 ,4 ]
Ding, Min-Rui [3 ]
Hu, Bing [1 ,2 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Inst Tradit Chinese Med Oncol, Shanghai, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Oncol, Shanghai, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Neurol, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Tradit Chinese Med, Sch Med, Shanghai, Peoples R China
基金
上海市自然科学基金; 中国国家自然科学基金;
关键词
colon cancer; Solanum nigrum L; network pharmacology; molecular docking; compounds; gene ontology; signal pathway; bioactivity; COLORECTAL-CANCER; SIGNALING PATHWAYS; APOPTOSIS; TARGET; CELLS; PROLIFERATION; GENES; CDK2;
D O I
10.3389/fonc.2023.1111799
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundSolanum nigrum L. (SNL) (Longkui) is a Chinese herb that can be used to treat colon cancer. The present study explored the components and mechanisms of SNL in treating colon cancer by using network pharmacology and molecular docking. MethodsThe components of SNL were collected from the TCMSP, ETCM, HERB, and NPASS databases. Meanwhile, the target proteins of these ingredients were collected/predicted by the TCMSP, SEA, SwissTargetPrediction, and the STITCH databases colon cancer-related target genes were identified from TCGA and GTEx databases. The interaction networks were established via Cytoscape 3.7.2. Gene Ontology and KEGG pathways were enriched by using the David 6.8 online tool. Finally, the binding of key components and targets was verified by molecular docking, and the cellular thermal shift assay (CETSA) was used to detect the efficiency of apigenin and kaempferol binding to the AURKB protein in CT26 cells. ResultsA total of 37 SNL components, 796 SNL targets, 5,356 colon cancer genes, and 241 shared targets of SNL and colon cancer were identified. A total of 43 key targets were obtained through topology analysis. These key targets are involved in multiple biological processes, such as signal transduction and response to drug and protein phosphorylation. At the same time, 104 signaling pathways, such as pathways in cancer, human cytomegalovirus infection, and PI3K-Akt signaling pathway, are also involved. The binding of the four key components (i.e., quercetin, apigenin, kaempferol, and luteolin) and the key targets was verified by molecular docking. The CETSA results showed that apigenin and kaempferol were able to bind to the AURKB protein to exert anti-CRC effects. ConclusionsQuercetin, apigenin, kaempferol, and luteolin are the main components of SNL in treating colon cancer. SNL regulates multiple bioprocesses via signaling pathways, such as pathways in cancer, PI3K-Akt, and cell cycle signaling pathways.
引用
收藏
页数:14
相关论文
共 50 条
[21]   Molecular mechanism of lycorine in the treatment of glioblastoma based on network pharmacology and molecular docking [J].
Jie Su ;
Mengmeng Huo ;
Fengnan Xu ;
Liqiong Ding .
Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 :1551-1559
[22]   Exploring the mechanism of Tingli Pill in the treatment of HFpEF based on network pharmacology and molecular docking [J].
Chi, Kuo ;
Yang, Saisai ;
Zhang, Yao ;
Zhao, Yongfa ;
Zhao, Jiahe ;
Chen, Qiuhan ;
Ge, Yuan ;
Liu, Jing .
MEDICINE, 2024, 103 (16) :E37727
[23]   Molecular mechanism of lycorine in the treatment of glioblastoma based on network pharmacology and molecular docking [J].
Su, Jie ;
Huo, Mengmeng ;
Xu, Fengnan ;
Ding, Liqiong .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (03) :1551-1559
[24]   Exploring the molecular mechanism of Lycium barbarum L. against breast cancer based on network pharmacology [J].
Hu, Zhiqiang ;
Ning, Mingliang ;
Qin, Shaojie ;
Yu, Kena .
JOURNAL OF FUNCTIONAL FOODS, 2023, 105
[25]   Exploring active ingredients and mechanisms of Coptidis Rhizoma-ginger against colon cancer using network pharmacology and molecular docking [J].
Zeng, Ting ;
Ling, Caijin ;
Liang, Yong .
TECHNOLOGY AND HEALTH CARE, 2024, 32 :S523-S542
[26]   Exploring the active components and mechanism of modified bazhen decoction in treatment of chronic cerebral circulation insufficiency based on network pharmacology and molecular docking [J].
Xu, Zhongbo ;
Shen, Manyang ;
Li, Lin .
MEDICINE, 2023, 102 (29) :E34341
[27]   Exploring the mechanism of action of Yiyi Fuzi Baijiang powder in colorectal cancer based on network pharmacology and molecular docking studies [J].
Yan, Hongting ;
Li, Yingjie ;
Yang, Bing ;
Long, Fengxi ;
Yang, Zhu ;
Tang, Dongxin .
BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2023, 39 (02) :1107-1127
[28]   Exploring the therapeutic mechanism of Zijin Ding in treating colorectal cancer based on network pharmacology and molecular docking [J].
Chen, Shaozhuang ;
Lin, Yufu ;
Chen, Fangwei ;
Chen, Yabo ;
Ding, Shan ;
Wang, Luming ;
Shen, Yun ;
Ye, Yanrong ;
Liu, Jia .
PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2025, 38 (03) :1029-1037
[29]   Revealing the molecular mechanism of baohuoside I for the treatment of breast cancer based on network pharmacology and molecular docking [J].
Mu, Junjie ;
Li, Ying ;
Chen, Qiuxiong ;
Xiao, Yujie ;
Hu, Min ;
He, Ziyue ;
Zeng, Jun ;
Ding, Yiling ;
Song, Pengyang ;
He, Xiao ;
Yang, Xian ;
Zhang, Xue .
JOURNAL OF ETHNOPHARMACOLOGY, 2025, 337
[30]   Molecular Mechanism of Salvia miltiorrhiza in the Treatment of Colorectal Cancer Based on Network Pharmacology and Molecular Docking Technology [J].
Jiang, Yi-Ling ;
Xun, Yi .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 :425-441